Versant Venture Management as of Dec. 31, 2020
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 12 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| CRISPR Therapeutics Common Shares (CRSP) | 48.3 | $466M | 3.0M | 153.11 | |
| Inari Medical Common Stock (NARI) | 20.8 | $201M | 2.3M | 87.29 | |
| Aligos Therapeutics Common Stock (ALGS) | 9.5 | $91M | 3.3M | 27.65 | |
| Adverum Biotechnologies Common Stock | 5.6 | $54M | 5.0M | 10.84 | |
| Flexion Therapeutics Common Stock | 4.6 | $44M | 3.8M | 11.54 | |
| Ocular Therapeutix Common Stock (OCUL) | 3.1 | $30M | 1.5M | 20.70 | |
| Crinetics Pharmaceuticals Common Stock (CRNX) | 3.0 | $29M | 2.0M | 14.11 | |
| Akero Therapeutics Common Stock (AKRO) | 2.1 | $20M | 778k | 25.80 | |
| Gritstone Oncology Common Stock (GRTS) | 1.8 | $18M | 4.5M | 3.94 | |
| Aprea Therapeutics Common Stock | 0.7 | $7.0M | 1.4M | 4.92 | |
| CymaBay Therapeutics Common Stock | 0.3 | $3.1M | 544k | 5.74 | |
| Clovis Oncology Common Stock | 0.1 | $489k | 102k | 4.80 |
